Magazine

Oracle: Larry Ellison Writes Another Big Check


The world's No. 2 software maker announced on Apr. 16 that it is buying Phase Forward (PFWD) for about $685 million. The Waltham (Mass.) company markets software that helps drug companies conduct clinical trials. Oracle (ORCL) CEO Larry Ellison has spent some $42 billion over the past five years on acquisitions aimed at boosting the company's profile in industries such as retail, telecom, and now health care.


Silicon Valley State of Mind
LIMITED-TIME OFFER SUBSCRIBE NOW

(enter your email)
(enter up to 5 email addresses, separated by commas)

Max 250 characters

 
blog comments powered by Disqus